Sysmex (OTCMKTS:SSMXY) Announces Quarterly Earnings Results

Sysmex (OTCMKTS:SSMXY) posted its earnings results on Tuesday. The company reported $0.10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.01), Zacks reports. The business had revenue of $895.73 million during the quarter, compared to the consensus estimate of $859.71 million. Sysmex had a return on equity of 8.01% and a net margin of 7.62%. Sysmex updated its FY 2026 guidance to 0.415-0.415 EPS.

Sysmex Trading Down 1.4%

Shares of SSMXY opened at $13.36 on Wednesday. Sysmex has a twelve month low of $8.01 and a twelve month high of $13.75. The company has a market cap of $8.12 billion, a P/E ratio of 31.80 and a beta of 1.19. The company has a current ratio of 3.40, a quick ratio of 2.53 and a debt-to-equity ratio of 0.23. The company’s fifty day simple moving average is $12.03 and its 200-day simple moving average is $10.05.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Sysmex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 18th. Two research analysts have rated the stock with a Hold rating. According to data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Sysmex Company Profile

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic testing instruments, reagents and related services. Its products are used by hospitals, clinical laboratories and other healthcare providers to analyze patient samples and support medical diagnosis. The company is best known for its hematology testing systems and also offers products for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory information systems and support services.